Unified Investment Management: EMR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Unified Investment Management on EMR, newest first. How the timeline and the estimate are built.
Unified Investment Management held 3,536 EMR shares at 2026-09-30 per its 13F-HR filed 2026-10-14.
the latest 13F is the newest step
- period ended2026-09-3013F 3,536 sharesChange vs previous 13F +58 shares
0.49% of the 13F portfolio, value $548,410.
13F-HR 0002085853-26-001170 filed by Unified Investment Management
Accepted , ingested - period ended2026-06-3013F 3,478 sharesChange vs previous 13F +47 shares
0.46% of the 13F portfolio, value $497,855.
13F-HR 0002085853-26-000871 filed by Unified Investment Management
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 3,431 sharesChange vs previous 13F -32 shares
0.46% of the 13F portfolio, value $449,503.
13F-HR 0002085853-26-000519 filed by Unified Investment Management
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 3,463 sharesChange vs previous 13F +37 shares
0.46% of the 13F portfolio, value $459,570.
13F-HR 0002085853-26-000224 filed by Unified Investment Management
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 3,426 sharesChange vs previous 13F +1,733 shares
0.45% of the 13F portfolio, value $449,372.
13F-HR 0002085853-25-000176 filed by Unified Investment Management
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,693 sharesChange vs previous 13F not available
0.24% of the 13F portfolio, value $225,762.
13F-HR 0001667731-25-000811 filed by Unified Investment Management
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).